Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Methodological quality

From: Effectiveness of transitional care interventions in patients with serious illness and their caregivers: a systematic review and metanalysis of randomized controlled trial

Citations

Q1

Q2

Q3

Q4

Q5

Q6

Q7

Q8

Q9

Q10

Q11

Q12

Q13

Total

%

Wong, et al. 2016

Y

Y

Y

U

U

N

Y

Y

Y

Y

Y

Y

U

9/13

69%

Ng AYM, et al. 2017

Y

Y

Y

N

N

N

Y

Y

Y

Y

Y

Y

Y

10/13

77%

Wang, et al. 2013

Y

N

Y

N

N

N

Y

Y

Y

Y

Y

Y

Y

9/13

69%

Vianello, et al. 2016

Y

N

Y

N

N

N

Y

N

Y

Y

Y

Y

Y

8/13

62%

Rogers, et al. 2017

Y

U

Y

N

N

N

Y

Y

Y

Y

Y

Y

U

8/13

62%

Nordly, et al. 2018

Y

Y

Y

N

N

N

Y

Y

Y

Y

Y

Y

Y

10/13

77%

Daly, et al. 2005

Y

U

Y

U

U

N

N

Y

Y

Y

Y

Y

Y

8/13

62%

Hanson, et al. 2019

Y

N

Y

N

N

Y

Y

N

Y

Y

Y

Y

Y

9/13

69%

Goldberg, et al. 2003

U

N

Y

N

U

Y

Y

Y

Y

Y

Y

Y

Y

9/13

69%

Smith, et al. 2014

Y

Y

Y

U

N

Y

Y

U

Y

Y

Y

Y

U

9/13

69%

Cleland, et al. 2005

Y

Y

U

N

N

N

N

Y

Y

Y

Y

Y

U

7/13

54%

Benzo, et al. 2019

Y

U

Y

N

N

N

Y

N

Y

Y

U

U

U

5/13

38%

Naylor, et al. 2004

Y

U

Y

N

N

Y

Y

Y

Y

Y

Y

Y

Y

10/13

77%

Hernandez, et al. 2014

Y

N

U

N

N

N

Y

Y

Y

Y

Y

Y

Y

8/13

62%

Total %

93%

38%

92%

0%

0%

28%

85%

71%

100%

100%

93%

93%

64%

  
  1. Note: two studies (Bernard et al., 2019; Griffin et al., 2023) were not included in this evaluations they have not been published yet
  2. Y, yes; N, No; U, Unclear
  3. JBI critical appraisal checklist for randomized controlled trials (RCTs):
  4. Q1. Was true randomization used for assignment of participants to treatment groups?
  5. Q2. Was allocation to treatment groups concealed?
  6. Q3. Were treatment groups similar at the baseline?
  7. Q4. Were participants blind to treatment assignment?
  8. Q5. Were those delivering treatment blind to treatment assignment?
  9. Q6. Were outcomes assessors blind to treatment assignment?
  10. Q7. Were treatment groups treated identically other than the intervention of interest?
  11. Q8. Was follow up complete and if not, were differences between groups in terms of their follow up adequately described and analyzed?
  12. Q9. Were participants analyzed in the groups to which they were randomized?
  13. Q10. Were outcomes measured in the same way for treatment groups?
  14. Q11. Were outcomes measured in a reliable way?
  15. Q12. Was appropriate statistical analysis used?
  16. Q13. Was the trial design appropriate, and any deviations from the standard RCT design (individual randomization, parallel groups) accounted for in the conduct and analysis of the trial?